Clinical Trial

Brain Activation and Satiety in Children 2

Study acronym: BASIC2
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Childhood obesity and related long-term effects are serious public health problems, but not all children with obesity do well in treatment. This study will test a new combination of family-based behavioral treatment (FBT) with a drug intervention using a glucagon-like peptide-1 receptor agonist (GLP-1RA) exenatide once weekly extended-release (ExQW, Bydureon®) in order to improve obesity intervention outcomes in 10-12-year-old children.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2020-08-17; most recent amendment 2025-12-31.
Status change: Recruiting → Active, Not Recruiting 2024-05-13
Status change: Not Yet Recruiting → Recruiting 2021-02-06
Trial Details
NCT Number NCT04520490
Lead Sponsor Seattle Children's Hospital
Collaborators: University of Washington
Conditions Childhood Obesity
Enrollment 63 participants
Start Date 2021-01-28
Primary Completion 2025-08-21 (estimated)
Study Completion 2026-02-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-05